Fabio
5.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relating to prescription drugs. | </b> </i>] [<i>Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit findings to the interim committees of Legislative Assembly related to health care not later than September 15, 2026.</i>] [<i>Sunsets on January 2, 2027.</i>] <b>Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board. Modifies the number of prescription drugs that may create affordability challenges that the board is directed to identify. Modifies the board's reporting requirements for the status of the generic drug market.</b> | us/states/or | Oregon Legislative Assembly | 2025R1 | SB 289 | Oregon SB 289 (2025R1) |
|
enacted | 5 | 22 | 4 | 2025-01-13T17:07:30+00:00 | 2025-06-06T22:13:28+00:00 | openstates | ocd-bill/f47bf739-8aba-4e02-9416-a2d6f5d3c0f8 | https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/SB289 | f647c519a9f62565fb02f14a25a292c11f0fd8a3c83f307c628aee48a9f1310f | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Oregon SB 289 (2025R1) — Relating to prescription drugs.
] [Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit findings to the interim committees of Legislative Assembly related to health care not later than September 15, 2026.] [Sunsets on January 2, 2027.] Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board. Modifies the number of prescription drugs that may create affordability challenges that the board is directed to identify. Modifies the board's reporting requirements for the status of the generic drug market.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Senate Amendments to Introduced (filed) — source
- A-Engrossed (committee substitute) — source
- SHC Amendment -1 (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Heard and Reported Out — 9–0 (pass) · lower
- Heard and Reported Out — 5–0 (pass) · upper
- Third reading. Carried by Munoz. Passed. — 49–1 (pass) · lower
- Third reading. Carried by Patterson. Passed. — 29–0 (pass) · upper
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-01-13T17:07:30+00:00 Introduction and first reading. Referred to President's desk.
introduction, reading-1, referral-committee - 2025-01-17T22:13:22+00:00 Referred to Health Care.
referral-committee - 2025-03-06T23:01:00+00:00 Public Hearing held.
- 2025-03-13T22:02:00+00:00 Work Session held.
- 2025-03-19T21:17:11+00:00 Recommendation: Do pass with amendments. (Printed A-Eng.)
committee-passage-favorable - 2025-03-20T18:48:59+00:00 Second reading.
reading-2 - 2025-03-24T19:07:28+00:00 Carried over to 03-25 by unanimous consent.
- 2025-03-25T18:00:05+00:00 Third reading. Carried by Patterson. Passed.
passage, reading-3 - 2025-03-25T18:01:05+00:00 Gelser Blouin, excused, granted unanimous consent to vote aye.
- 2025-03-27T18:58:01+00:00 First reading. Referred to Speaker's desk.
introduction, reading-1, referral-committee - 2025-04-01T23:21:45+00:00 Referred to Behavioral Health and Health Care.
referral-committee - 2025-04-15T22:01:00+00:00 Public Hearing held.
- 2025-05-06T22:02:00+00:00 Work Session held.
- 2025-05-12T20:15:13+00:00 Recommendation: Do pass.
committee-passage-favorable - 2025-05-13T18:58:56+00:00 Second reading.
reading-2 - 2025-05-14T19:43:54+00:00 Rules suspended. Carried over to May 15, 2025 Calendar.
- 2025-05-15T19:44:57+00:00 Third reading. Carried by Munoz. Passed.
passage, reading-3 - 2025-05-19T19:36:04+00:00 President signed.
passage - 2025-05-20T17:35:37+00:00 Speaker signed.
passage - 2025-05-28T00:03:09+00:00 Governor signed.
executive-signature - 2025-06-06T22:01:42+00:00 Chapter 166, 2025 Laws.
- 2025-06-06T22:13:28+00:00 Effective date, January 1, 2026.
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f47bf739-8aba-4e02-9416-a2d6f5d3c0f8. Confidence: reported (aggregated from official Oregon legislature records).